Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes

Active, not recruiting

Conditions: Lynch Syndrome
Hereditary Colonic Polyposis Syndromes

Interventions: Genetic: colonic biopsies
Genetic: questionnaires

First Posted Date: 2015-02-25

Last Posted Date: 2025-02-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 77

Registration Number: NCT02371135

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients

Not Applicable

Completed

Conditions: Breast Cancer
Peripheral Neuropathy

Interventions: Procedure: Acupuncture
Behavioral: Neuropathic Pain Scale (NPS) questionnaire
Behavioral: FACT/GOG-Ntx questionnaire

First Posted Date: 2015-02-18

Last Posted Date: 2023-06-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT02364726

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

Genomic Predictors of Papillary Microcarcinoma Disease Progression

Recruiting

Conditions: Papillary Microcarcinoma

First Posted Date: 2015-02-16

Last Posted Date: 2024-12-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 500

Registration Number: NCT02363595

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Animal Assisted Activity Program on Patients and Staff on an Inpatient Surgical Oncology Unit

Completed

Conditions: Postoperative Care

Interventions: Other: standard post surgery care
Behavioral: Caring Canine program
Behavioral: baseline and post assessment

First Posted Date: 2015-02-16

Last Posted Date: 2017-01-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 146

Registration Number: NCT02363608

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

Not Applicable

Terminated

Conditions: Non-Hodgkin's Lymphoma
Leukemia
Myelodysplastic Syndrome

Interventions: Drug: Cyclophosphamide

First Posted Date: 2015-02-10

Last Posted Date: 2019-07-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3

Registration Number: NCT02360111

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial

Conditions: Neuroendocrine Tumors

First Posted Date: 2015-02-06

Last Posted Date: 2016-11-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT02358018

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Choosing Options for Insomnia in Cancer Effectively (CHOICE): A Comparative Effectiveness Trial of Acupuncture and Cognitive Behavior Therapy

Not Applicable

Completed

Conditions: Insomnia
Cancer

Interventions: Other: Acupuncture
Other: Cognitive Behavior Therapy

First Posted Date: 2015-02-05

Last Posted Date: 2022-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 160

Registration Number: NCT02356575

Locations: 🇺🇸
Abramson Cancer Center of The University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs

Phase 2

Completed

Conditions: Advanced Stage Non-small Cell Lung Cancer

Interventions: Drug: nivolumab
Drug: pilimumab

First Posted Date: 2015-01-30

Last Posted Date: 2024-05-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 29

Registration Number: NCT02350764

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation

Phase 2

Terminated

Conditions: Hematopoietic Stem Cell Transplant
Poor Marrow Graft Function

Interventions: Device: CliniMACS Cell Selection System

First Posted Date: 2015-01-30

Last Posted Date: 2018-10-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 4

Registration Number: NCT02350777

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies

Phase 1

Completed

Conditions: Neuroendocrine Tumors

Interventions: Radiation: 18F-MFBG (meta-fluoro benzylguanidine)
Device: Positron emission tomography (PET) imaging
Other: Blood draws

First Posted Date: 2015-01-28

Last Posted Date: 2025-03-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 48

Registration Number: NCT02348749

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy